β-Caryophyllene-13C,d2

CAT:
804-HY-N1415S1
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
β-Caryophyllene-13C,d2 - image 1

β-Caryophyllene-13C,d2

  • UNSPSC Description:

    β-Caryophyllene-13C,d2 is 13C and deuterated labeled trans,trans-2,4-Decadienal (HY-W013627). trans,trans-2,4-Decadienal is a lipid peroxidation product of linolieic acid[1].
  • Target Antigen:

    Cannabinoid Receptor; Endogenous Metabolite; Isotope-Labeled Compounds
  • Type:

    Isotope-Labeled Compounds
  • Related Pathways:

    GPCR/G Protein;Metabolic Enzyme/Protease;Neuronal Signaling;Others
  • Applications:

    Cancer-programmed cell death
  • Field of Research:

    Cancer
  • Solubility:

    10 mM in DMSO
  • Smiles:

    CC1([C@@]2([H])[C@](/C(CC/C=C(CC2)/C)=[13C]([2H])\[2H])([H])C1)C
  • Molecular Weight:

    207.36
  • References & Citations:

    [1]Cheng Y, et al. β-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPARγ pathway. Pharmacology. 2014;94(1-2):1-12.|[2]Dahham SS, et al. The Anticancer, Antioxidant and Antimicrobial Properties of the Sesquiterpene β-Caryophyllenefrom the Essential Oil of Aquilaria crassna. Molecules. 2015 Jun 26;20(7):11808-29.|[3]de Oliveira CC, et al. Anticonvulsant activity of β-caryophyllene against pentylenetetrazol-induced seizures. Epilepsy Behav. 2016 Mar;56:26-31.|[4]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.
  • Shipping Conditions:

    Room temperature
  • Clinical Information:

    No Development Reported